Financials

  • Market Capitalization 70.39 M
  • Employee 6
  • Founded 2000
  • CEO Yuichi Iwaki
  • Website www.medicinova.com
  • Headquarter Delaware, United States
  • FIGI BBG000RDP030
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.29
Relación precio/flujo de caja
70.51

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
4083
ANVS
Annovis Bio, Inc. Common Stock
1.70 USD-2.30%-8.60%-3.95%-26.41%72.43 M USD
4085
NRXS
Neuraxis, Inc. Common Stock
5.74 USD-4.17%-7.42%-10.73%+5.71%72.08 M USD
4101
CSBR
Champions Oncology, Inc. - Common Stock
5.00 USD0.00%+1.21%-4.94%-24.92%69.47 M USD
4105
SPRO
Spero Therapeutics, Inc. - Common Stock
1.20 USD-1.64%-1.64%+1.69%-41.18%69.88 M USD

Noticias